Update

2018 AASLD guidance recommends OCALIVA as the only approved second-line treatment option for PBC3 SEE THE GUIDELINES

OCALIVA Sitemap

 

 

OCALICA obeticholic acid

Enroll for updates

REGISTER FOR UPDATES

Register for Updates Close

*Required fields. Invalid entry. Please try again.

First name required
Last name required
Email required
Specialty Profession required


REGISTER


 

Thank you for your interest

You can expect a confirmation email shortly to set your preferences.

OCALIVA® (obeticholic acid)

Patient Assistance: 1-844-622-4278

This site is intended for US healthcare professionals only Home Visit Patient Site Prescribing Information Important Safety Information

Patient Assistance:
1-844-622-4278

You are about to leave Ocalivahcp.com

Click CONTINUE to go to the page you requested or click CANCEL to remain on this page.

Cancel Continue